Brain-computer Interface Commercial Readiness
NCT: NCT06521736 · COMPLETED
Brief Summary
The goal of this clinical trial is to evaluate the commercial readiness of an Augmentative and Alternative Communication Brain-Computer Interface (AAC-BCI) device for people with minimal movement who benefit from expressive communication technology. Our clinical trial focuses on up to 8 AAC-BCI users but involves a team of support participants with different roles: an industry partner's consultant, a speech language pathologist (SLP), and the user's in-home support person. Patient and team reported outcome measures data will be collected on usage, performance, reliability and comfort along with performance data of using the AAC-BCI device in the home.
Frequently Asked Questions
What is Brain-computer Interface Commercial Readiness?
Brain-computer Interface Commercial Readiness is a clinical trial registered under NCT06521736. Current status: COMPLETED.
What is the status of NCT06521736?
The current status of NCT06521736 (Brain-computer Interface Commercial Readiness) is: COMPLETED.
When did Brain-computer Interface Commercial Readiness start?
Brain-computer Interface Commercial Readiness started on 2024-09-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.